---
$id: https://graph.org.ai/products/commodity/51263005
$type: Product
source: UNSPSC
code: "51263005"
title: "Zolertine"
class: "51263000"
classTitle: "Adrenergic blocking agent piperazines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zolertine

**UNSPSC Code**: 51263005
**Class**: [Adrenergic blocking agent piperazines](Adrenergic blocking agent piperazines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C13H18N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EMD433OT6A, chemically known as piperazine, 1-phenyl-4-(2-(1h-tetrazol-5-yl)ethyl)- but generally known as zolertine, which bears US NIH Compound Identifier 23669. European Medicines Agency schedules Zolertine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00178MIG. The term ZOLERTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). ZOLERTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zolertine under HS 29335995 and SITC 51576. As of Q4 2014, ZOLERTINE remains the US FDA Preferred Term for this commodity. Zolertine bears US NLM identifiers UMLS ID C0078838 and NCI Concept Code C82223. SMILES: N1(CCN(CC1)C1CCCCC1)CCC1N[NH]NN1.

